Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Lymphoma

Free Subscription Articles published in Br J Haematol Retrieve available abstracts of 128 articles: HTML format Text format

Single Articles

February 2012
1. SANDLUND JT
   Burkitt lymphoma: staging and response evaluation.
   Br J Haematol. 2012 Feb 1. doi: 10.1111/j.1365-2141.2012.09026.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
2. MILES RR , Arnold S, Cairo MS
   Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
   Br J Haematol. 2012 Jan 20. doi: 10.1111/j.1365-2141.2011.09024.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. MAGRATH I
   Epidemiology: clues to the pathogenesis of Burkitt lymphoma.
   Br J Haematol. 2012 Jan 20. doi: 10.1111/j.1365-2141.2011.09013.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. EPSTEIN A
   Burkitt lymphoma and the discovery of Epstein-Barr virus.
   Br J Haematol. 2012 Jan 11. doi: 10.1111/j.1365-2141.2011.09008.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. MITROVIC Z , Bast M, Bierman PJ, Bociek RG, et al
   The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma.
   Br J Haematol. 2012 Jan 9. doi: 10.1111/j.1365-2141.2011.08998.
   PubMed     Text format     Related articles   
   
   
   
   
6. GREAVES P , Wilson A, Matthews J, Brown DL, et al
   Early relapse and refractory disease remain risk factors in the anthracycline and autologous transplant era for patients with relapsed/refractory classical Hodgkin lymphoma: a single centre intention-to-treat analysis.
   Br J Haematol. 2012 Jan 9. doi: 10.1111/j.1365-2141.2011.08993.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. WONDERGEM MJ , Zijlstra JM, de Rooij M, Visser OJ, et al
   Improving survival in patients with transformed B cell non Hodgkin lymphoma: consolidation with (90) Yttrium ibritumomab tiuxetan-BEAM and autologous stem cell transplantation.
   Br J Haematol. 2012 Jan 9. doi: 10.1111/j.1365-2141.2011.08991.
   PubMed     Text format     Related articles   
   
   
   
   
8. WAN MY , Ardeshna KM, Bomanji J
   Neurolymphomatosis in a patient with lymphoblastic lymphoma.
   Br J Haematol. 2012 Jan 6. doi: 10.1111/j.1365-2141.2011.09002.
   PubMed     Text format     Related articles   
   
   
   
   December 2011
9. MCNAMARA C , Davies J, Dyer M, Hoskin P, et al
   Guidelines on the investigation and management of follicular lymphoma.
   Br J Haematol. 2011 Dec 23. doi: 10.1111/j.1365-2141.2011.08969.
   PubMed     Text format     Related articles   
   
   
   
   
10. AI WZ , Chang ET, Fish K, Fu K, et al
    Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study.
    Br J Haematol. 2011 Dec 20. doi: 10.1111/j.1365-2141.2011.08982.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. KELLY KM
    Management of children with high-risk Hodgkin lymphoma.
    Br J Haematol. 2011 Dec 20. doi: 10.1111/j.1365-2141.2011.08975.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. BARTH MJ , Hernandez-Ilizaliturri FJ, Mavis C, Tsai PC, et al
    Ofatumumab demonstrates activity against rituximab-sensitive and -resistant cell lines, lymphoma xenografts and primary tumour cells from patients with B-cell lymphoma.
    Br J Haematol. 2011 Dec 9. doi: 10.1111/j.1365-2141.2011.08966.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. MARZOLINI M , Wong WL, Ardeshna K, Padhani A, et al
    Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma.
    Br J Haematol. 2011 Dec 8. doi: 10.1111/j.1365-2141.2011.08959.
    PubMed     Text format     Related articles   
    
    
    
    
14. MERLI F , Luminari S, Ilariucci F, Petrini M, et al
    Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi.
    Br J Haematol. 2011 Dec 7. doi: 10.1111/j.1365-2141.2011.08958.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
15. WAHLIN BE , Yri OE, Kimby E, Holte H, et al
    Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times.
    Br J Haematol. 2011 Nov 30. doi: 10.1111/j.1365-2141.2011.08942.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. OBRADOR-HEVIA A , Serra-Sitjar M, Rodriguez J, Villalonga P, et al
    The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival.
    Br J Haematol. 2011 Nov 23. doi: 10.1111/j.1365-2141.2011.08951.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. CORAZZELLI G , Frigeri F, Russo F, Frairia C, et al
    RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma.
    Br J Haematol. 2011 Nov 21. doi: 10.1111/j.1365-2141.2011.08947.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. NAKAYAMA-ICHIYAMA S , Iwaki K, Yokote T, Tsuji M, et al
    Expression of multiple cytokines and CCR4 in primary testicular diffuse large B-cell lymphoma, not otherwise specified, involving the skin.
    Br J Haematol. 2011 Nov 21. doi: 10.1111/j.1365-2141.2011.08943.
    PubMed     Text format     Related articles   
    
    
    
    
19. TAOKA K , Yamamoto G, Kaburaki T, Takahashi T, et al
    Treatment of primary intraocular lymphoma with rituximab, high dose methotrexate, procarbazine, and vincristine chemotherapy, reduced whole-brain radiotherapy, and local ocular therapy.
    Br J Haematol. 2011 Nov 16. doi: 10.1111/j.1365-2141.2011.08938.
    PubMed     Text format     Related articles   
    
    
    
    
20. NABHAN C , Smith SM, Helenowski I, Ramsdale E, et al
    Analysis of very elderly (>/=80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcome.
    Br J Haematol. 2011 Nov 16. doi: 10.1111/j.1365-2141.2011.08934.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. BARANISKIN A , Deckert M, Schulte-Altedorneburg G, Schlegel U, et al
    Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system.
    Br J Haematol. 2011 Nov 11. doi: 10.1111/j.1365-2141.2011.08928.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. NOVAK U , Basso K, Pasqualucci L, Dalla-Favera R, et al
    Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells.
    Br J Haematol. 2011;155:362-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
23. BOCKORNY B , Codreanu I, Dasanu CA
    Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature.
    Br J Haematol. 2011 Oct 24. doi: 10.1111/j.1365-2141.2011.08907.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. SCHIFFMAN JD , Lorimer PD, Rodic V, Jahromi MS, et al
    Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression.
    Br J Haematol. 2011 Oct 8. doi: 10.1111/j.1365-2141.2011.08883.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. TADMOR T , Bejar J, Attias D, Polliack A, et al
    Richter syndrome in chronic lymphocytic leukaemia manifesting only as tumorous hepatomegaly.
    Br J Haematol. 2011;155:135.
    PubMed     Text format     Related articles   
    
    
    
    
26. NEBRAL K , Krehan D, Strehl S
    Expression of PAX5 splice variants: a phenomenon of stress-induced, illegitimate splicing?
    Br J Haematol. 2011;155:277-80.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
27. SVENSSON M , Dahlin U, Kimby E
    Better response with conjugate vaccine than with polysaccaride vaccine 12 months after rituximab treatment in lymphoma patients.
    Br J Haematol. 2011 Sep 19. doi: 10.1111/j.1365-2141.2011.08867.
    PubMed     Text format     Related articles   
    
    
    
    
28. LINCH DC
    Burkitt lymphoma in adults.
    Br J Haematol. 2011 Sep 19. doi: 10.1111/j.1365-2141.2011.08877.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. KASSAM S , Juliger S, Jia L, Joel SP, et al
    Methylseleninic acid antagonizes the cytotoxic effect of bortezomib in mantle cell lymphoma cell lines through modulation of Bcl-2 family proteins.
    Br J Haematol. 2011 Sep 13. doi: 10.1111/j.1365-2141.2011.08861.
    PubMed     Text format     Related articles   
    
    
    
    
30. WARD E , Mittereder N, Kuta E, Sims GP, et al
    A glycoengineered anti-CD19 antibody with potent antibody-dependent cellular cytotoxicity activity in vitro and lymphoma growth inhibition in vivo.
    Br J Haematol. 2011 Sep 9. doi: 10.1111/j.1365-2141.2011.08857.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. BOUTELOUP M , Verney A, Rachinel N, Callet-Bauchu E, et al
    MicroRNA expression profile in splenic marginal zone lymphoma.
    Br J Haematol. 2011 Sep 9. doi: 10.1111/j.1365-2141.2011.08848.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
32. WONG HK , Mishra A, Hake T, Porcu P, et al
    Evolving Insights in the Pathogenesis and Therapy of Cutaneous T-cell lymphoma (Mycosis Fungoides and Sezary Syndrome).
    Br J Haematol. 2011 Aug 25. doi: 10.1111/j.1365-2141.2011.08852.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. CHANG JE , Peterson C, Choi S, Eickhoff JC, et al
    VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study.
    Br J Haematol. 2011 Aug 16. doi: 10.1111/j.1365-2141.2011.08820.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. AL-NAWAKIL C , Park S, Chapuis N, Dreyfus F, et al
    Salvage therapy of Autoimmune Thrombocytopenic Purpura revealing non-Hodgkin Lymphoma by the thrombopoietin receptor agonist romiplostim.
    Br J Haematol. 2011 Aug 16. doi: 10.1111/j.1365-2141.2011.08825.
    PubMed     Text format     Related articles   
    
    
    
    
35. SHUSTOV A , Cherian S, Shaw A, Lupinacci TA, et al
    In-vivo purging of the circulating clonal T-cells with Alemtuzumab prior to autologous peripheral blood hematopoietic cell mobilization and transplantation.
    Br J Haematol. 2011;154:415-8.
    PubMed     Text format     Related articles   
    
    
    
    
36. ALEXANDROFF AB , Shpadaruk V, Bamford WM, Kennedy DB, et al
    Alemtuzumab-resistant Sezary syndrome responding to zanolimumab.
    Br J Haematol. 2011;154:419-21.
    PubMed     Text format     Related articles   
    
    
    
    
37. STEVENS J , Waters R, Sieniawska C, Kassam S, et al
    Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies.
    Br J Haematol. 2011;154:448-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
38. PAYNE K , Wright P, Grant JW, Huang Y, et al
    BIOMED-2 PCR assays for IGK gene rearrangements are essential for B-cell clonality analysis in follicular lymphoma.
    Br J Haematol. 2011 Jul 26. doi: 10.1111/j.1365-2141.2011.08803.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. GANDHI SA , Mufti G, Devereux S, Ireland R, et al
    Primary effusion lymphoma in an HIV-negative man.
    Br J Haematol. 2011 Jul 18. doi: 10.1111/j.1365-2141.2011.08778.
    PubMed     Text format     Related articles   
    
    
    
    
40. MRAZ M , Zent CS, Church AK, Jelinek DF, et al
    Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin alpha-4-beta-1 (VLA-4) with natalizumab can overcome this resistance.
    Br J Haematol. 2011 Jul 12. doi: 10.1111/j.1365-2141.2011.08794.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. AL-SHIEBAN S , Byrne E, Trivedi P, Morilla R, et al
    Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patients.
    Br J Haematol. 2011 Jul 2. doi: 10.1111/j.1365-2141.2011.08760.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. NARESH KN , Ibrahim HA, Lazzi S, Rince P, et al
    Diagnosis of Burkitt lymphoma using an algorithmic approach - applicable in both resource-poor and resource-rich countries.
    Br J Haematol. 2011 Jul 1. doi: 10.1111/j.1365-2141.2011.08771.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
43. CORAZZELLI G , Frigeri F, Arcamone M, Lucania A, et al
    Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy.
    Br J Haematol. 2011 Jun 28. doi: 10.1111/j.1365-2141.2011.08786.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. CZUCZMAN MS , Vose JM, Witzig TE, Zinzani PL, et al
    The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin.
    Br J Haematol. 2011 Jun 28. doi: 10.1111/j.1365-2141.2011.08781.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. SEKIMIZU M , Sunami S, Nakazawa A, Hayashi Y, et al
    Chromosome abnormalities in advanced stage T-cell lymphoblastic lymphoma of children and adolescents: a report from Japanese Paediatric Leukaemia/Lymphoma Study Group (JPLSG) and review of the literature.
    Br J Haematol. 2011 Jun 21. doi: 10.1111/j.1365-2141.2011.08788.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. CHEN KW , Yang CF, Huang CT, Chiou TJ, et al
    Molluscum contagiosum in a patient with adult T-cell leukaemia/lymphoma.
    Br J Haematol. 2011 Jun 17. doi: 10.1111/j.1365-2141.2011.08776.
    PubMed     Text format     Related articles   
    
    
    
    
47. BREM EA , Thudium K, Khubchandani S, Tsai PC, et al
    Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas.
    Br J Haematol. 2011;153:599-611.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
48. NOJIMA J , Motoki Y, Tsuneoka H, Kuratsune H, et al
    'Oxidation stress index' as a possible clinical marker for the evaluation of non-Hodgkin lymphoma.
    Br J Haematol. 2011 May 4. doi: 10.1111/j.1365-2141.2011.08719.
    PubMed     Text format     Related articles   
    
    
    
    
49. NG AK
    Review of the cardiac long-term effects of therapy for Hodgkin lymphoma.
    Br J Haematol. 2011 May 3. doi: 10.1111/j.1365-2141.2011.08713.
    PubMed     Text format     Related articles   
    
    
    
    
50. LU SJ , Sinha AK
    Peritoneal lymphomatosis shown on positron emission tomography/computed tomography scanning.
    Br J Haematol. 2011;153:290.
    PubMed     Text format     Related articles   
    
    
    
    
51. LEADER A , Lishner M, Michaeli J, Revel A, et al
    Fertility considerations and preservation in haemato-oncology patients undergoing treatment.
    Br J Haematol. 2011;153:291-308.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. HINCKS I , Woodcock BE, Thachil J
    Is rituximab-induced late-onset neutropenia a good prognostic indicator in lymphoproliferatve disorders?
    Br J Haematol. 2011;153:411-3.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
53. CHANUDET E , Huang Y, Zeng N, Streubel B, et al
    TNFAIP3 abnormalities in MALT lymphoma with autoimmunity.
    Br J Haematol. 2011 Apr 26. doi: 10.1111/j.1365-2141.2011.08624.
    PubMed     Text format     Related articles   
    
    
    
    
54. NAKAYAMA-ICHIYAMA S , Yokote T, Iwaki K, Miyoshi T, et al
    Co-infection of human herpesvirus-6 and human herpesvirus-8 in primary cutaneous diffuse large B-cell lymphoma, leg type.
    Br J Haematol. 2011 Apr 26. doi: 10.1111/j.1365-2141.2011.08702.
    PubMed     Text format     Related articles   
    
    
    
    
55. FANALE M , Fayad L, Pro B, Samaniego F, et al
    Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma.
    Br J Haematol. 2011 Apr 26. doi: 10.1111/j.1365-2141.2011.08618.
    PubMed     Text format     Related articles   
    
    
    
    
56. YOSHIDA T , Sato K, Ozaki K, Matsuyama T, et al
    Bone involvement in a patient with Hodgkin lymphoma producing granulocyte colony stimulating factor: PET imaging.
    Br J Haematol. 2011 Apr 22. doi: 10.1111/j.1365-2141.2011.08686.
    PubMed     Text format     Related articles   
    
    
    
    
57. ULLRICH K , Wurster KD, Lamprecht B, Kochert K, et al
    BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines.
    Br J Haematol. 2011 Apr 22. doi: 10.1111/j.1365-2141.2011.08685.
    PubMed     Text format     Related articles   
    
    
    
    
58. GILL H , Trendell-Smith NJ, Loong F, Chan JC, et al
    Paraneoplastic pemphigus due to natural-killer/T-cell lymphoma.
    Br J Haematol. 2011 Apr 22. doi: 10.1111/j.1365-2141.2011.08645.
    PubMed     Text format     Related articles   
    
    
    
    
59. NAKAYAMA-ICHIYAMA S , Yokote T, Iwaki K, Takubo T, et al
    Hypercalcaemia in diffuse large B-cell lymphoma with expression of both parathyroid hormone-related protein and its receptor.
    Br J Haematol. 2011 Apr 22. doi: 10.1111/j.1365-2141.2010.08530.
    PubMed     Text format     Related articles   
    
    
    
    
60. SAARINEN S , Vahteristo P, Launonen V, Franssila K, et al
    Analysis of KLHDC8B in familial nodular lymphocyte predominant Hodgkin lymphoma.
    Br J Haematol. 2011 Apr 22. doi: 10.1111/j.1365-2141.2010.08528.
    PubMed     Text format     Related articles   
    
    
    
    
61. HEMMAWAY C , Laverse E, Nicholas M, Nagy Z, et al
    Cerebellar Cladophialophora bantiana infection in a patient with marginal zone lymphoma treated with immunochemotherapy including rituximab.
    Br J Haematol. 2011 Apr 21. doi: 10.1111/j.1365-2141.2011.08673.
    PubMed     Text format     Related articles   
    
    
    
    
62. SHIRAMIZU B , Goldman S, Kusao I, Agsalda M, et al
    Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children's oncology group report.
    Br J Haematol. 2011 Apr 18. doi: 10.1111/j.1365-2141.2011.08681.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. NIITSU N , Hayama M, Yoshino T, Nakamura S, et al
    Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers.
    Br J Haematol. 2011 Apr 15. doi: 10.1111/j.1365-2141.2011.08634.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. TESTONI M , Kwee I, Greiner TC, Montes-Moreno S, et al
    Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP.
    Br J Haematol. 2011 Apr 13. doi: 10.1111/j.1365-2141.2011.08675.
    PubMed     Text format     Related articles   
    
    
    
    
65. DEARDEN CE , Johnson R, Pettengell R, Devereux S, et al
    Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).
    Br J Haematol. 2011 Apr 11. doi: 10.1111/j.1365-2141.2011.08651.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. ANDERSSON A , Enblad G, Gustavsson A, Erlanson M, et al
    Long term risk of infections in Hodgkin lymphoma long-term survivors.
    Br J Haematol. 2011 Apr 7. doi: 10.1111/j.1365-2141.2011.08638.
    PubMed     Text format     Related articles   
    
    
    
    
67. BAI LY , Ma Y, Kulp SK, Wang SH, et al
    OSU-DY7, a novel D-tyrosinol derivative, mediates cytotoxicity in chronic lymphocytic leukaemia and Burkitt lymphoma through p38 mitogen-activated protein kinase pathway.
    Br J Haematol. 2011 Apr 7. doi: 10.1111/j.1365-2141.2010.08443.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
68. BUTTERBACH K , Beckmann L, de Sanjose S, Benavente Y, et al
    Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph).
    Br J Haematol. 2011 Mar 21. doi: 10.1111/j.1365-2141.2011.08632.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. CHIGRINOVA E , Mian M, Shen Y, Greiner TC, et al
    Integrated profiling of diffuse large B-cell lymphoma with 7q gain.
    Br J Haematol. 2011 Mar 21. doi: 10.1111/j.1365-2141.2011.08628.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. LAN Q , Wang SS, Menashe I, Armstrong B, et al
    Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
    Br J Haematol. 2011 Mar 21. doi: 10.1111/j.1365-2141.2010.08424.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. DYER MJ , Ye H, Isaacson PG
    Primary lymphoma-like lesions of the uterine cervix; sheep in wolves' clothing.
    Br J Haematol. 2011 Mar 16. doi: 10.1111/j.1365-2141.2011.08659.
    PubMed     Text format     Related articles   
    
    
    
    
72. SMITH SD , Moskowitz CH, Dean R, Pohlman B, et al
    Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres.
    Br J Haematol. 2011 Mar 16. doi: 10.1111/j.1365-2141.2011.08616.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. SIBON D , Ertault M, Al Nawakil C, de Bazelaire C, et al
    Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients.
    Br J Haematol. 2011 Mar 8. doi: 10.1111/j.1365-2141.2011.08594.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. FERNANDEZ DE LARREA C , Martinez-Pozo A, Mercadal S, Garcia A, et al
    Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphoma.
    Br J Haematol. 2011 Mar 6. doi: 10.1111/j.1365-2141.2011.08596.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. WATANABE N , Noh JY, Narimatsu H, Takeuchi K, et al
    Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24 553 patients with Hashimoto's disease.
    Br J Haematol. 2011 Mar 4. doi: 10.1111/j.1365-2141.2011.08606.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. EIDE MB , Lauritzsen GF, Kvalheim G, Kolstad A, et al
    High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study.
    Br J Haematol. 2011;152:600-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. 
    Retraction: a modified version of galectin-9 induces cell cycle arrest and apoptosis of Burkitt and Hodgkin lymphoma cells.
    Br J Haematol. 2011;152:788.
    PubMed     Text format     Related articles   
    
    
    
    
78. CAPELLO D , Gloghini A, Martini M, Spina M, et al
    Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomas.
    Br J Haematol. 2011;152:777-80.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
79. D'ALO F , Leone G, Hohaus S, Teofili L, et al
    Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome.
    Br J Haematol. 2011 Feb 20. doi: 10.1111/j.1365-2141.2010.08438.
    PubMed     Text format     Related articles   
    
    
    
    
80. NAKAYAMA-ICHIYAMA S , Yokote T, Hiraoka N, Takubo T, et al
    Expression of multiple cytokines and cutaneous lymphocyte antigen in adult T-cell leukaemia/lymphoma cells with tumour progression and skin involvement.
    Br J Haematol. 2011 Feb 20. doi: 10.1111/j.1365-2141.2011.08584.
    PubMed     Text format     Related articles   
    
    
    
    
81. RASI S , Spina V, Bruscaggin A, Vaisitti T, et al
    A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome.
    Br J Haematol. 2011;152:284-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. CHAPUY B , Schuelper N, Panse M, Dohm A, et al
    Multikinase inhibitor sorafenib exerts cytocidal efficacy against Non-Hodgkin lymphomas associated with inhibition of MAPK14 and AKT phosphorylation.
    Br J Haematol. 2011;152:401-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
83. MCPHAIL ER , Law ME, Decker PA, O'Neill BP, et al
    Influence of 6q22-23 on overall survival in primary central nervous system lymphoma. Analysis of North Central Cancer Treatment Group trials 86 72 52, 93 73 51 and 96 73 51.
    Br J Haematol. 2011 Jan 31. doi: 10.1111/j.1365-2141.2010.08564.
    PubMed     Text format     Related articles   
    
    
    
    
84. HOSGOOD HD 3RD , Purdue MP, Wang SS, Zheng T, et al
    A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.
    Br J Haematol. 2011 Jan 20. doi: 10.1111/j.1365-2141.2010.08518.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. HILL BT , Rybicki L, Bolwell BJ, Smith S, et al
    The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls.
    Br J Haematol. 2011 Jan 12. doi: 10.1111/j.1365-2141.2010.08549.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. DUCASSOU S , Ferlay C, Bergeron C, Girard S, et al
    Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951.
    Br J Haematol. 2011 Jan 7. doi: 10.1111/j.1365-2141.2010.08541.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. KWONG YL , Khong PL
    Central palatal perforation in nasal natural killer cell lymphoma.
    Br J Haematol. 2011;152:2.
    PubMed     Text format     Related articles   
    
    
    
    
88. WAGNER SD , Ahearne M, Ferrigno PK
    The role of BCL6 in lymphomas and routes to therapy.
    Br J Haematol. 2011;152:3-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
89. GALLAMINI A , Patti C, Viviani S, Rossi A, et al
    Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.
    Br J Haematol. 2010 Dec 20. doi: 10.1111/j.1365-2141.2010.08485.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. CORRADINI P , Sarina B, Farina L
    Allogeneic transplantation for Hodgkin's lymphoma.
    Br J Haematol. 2010 Dec 13. doi: 10.1111/j.1365-2141.2010.08492.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. DAW S , Wynn R, Wallace H
    Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescents.
    Br J Haematol. 2010 Dec 7. doi: 10.1111/j.1365-2141.2010.08455.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. RINALDI A , Forconi F, Arcaini L, Mian M, et al
    Immunogenetics features and genomic lesions in splenic marginal zone lymphoma.
    Br J Haematol. 2010;151:435-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. RAPANOTTI MC , Caruso R, Ammatuna E, Zaza S, et al
    Molecular characterization of paediatric idiopathic hypereosinophilia.
    Br J Haematol. 2010;151:440-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
94. ALDINUCCI D , Celegato M, Borghese C, Colombatti A, et al
    IRF4 silencing inhibits Hodgkin lymphoma cell proliferation, survival and CCL5 secretion.
    Br J Haematol. 2010 Nov 28. doi: 10.1111/j.1365-2141.2010.08497.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. MIURA Y , Matsui Y, Sugino N, Nakato Y, et al
    Intravascular large B-cell lymphoma cells in the bone marrow smear preparation.
    Br J Haematol. 2010 Nov 25. doi: 10.1111/j.1365-2141.2010.08487.
    PubMed     Text format     Related articles   
    
    
    
    
96. MOHAMEDBHAI SG , Sibson K, Marafioti T, Kayani I, et al
    Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%
    Br J Haematol. 2010 Nov 24. doi: 10.1111/j.1365-2141.2010.08447.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. REZAEI N , Mahmoudi E, Aghamohammadi A, Das R, et al
    X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma.
    Br J Haematol. 2010 Nov 18. doi: 10.1111/j.1365-2141.2010.08442.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. BAYRAKTAR S , Bayraktar UD, Stefanovic A, Lossos IS, et al
    Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients.
    Br J Haematol. 2010 Nov 18. doi: 10.1111/j.1365-2141.2010.08429.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. MALAK S , Durrand V
    Follicular lymphoma transformed to an aggressive Burkitt-like lymphoma with acquisition of MYC rearrangement.
    Br J Haematol. 2010;151:294.
    PubMed     Text format     Related articles   
    
    
    
    October 2010
100. THIELEN C , Bisig B, Gofflot S, Herens C, et al
     CHIC cells: a novel ALK+ cell line derived from a relapsed anaplastic large cell lymphoma.
     Br J Haematol. 2010 Oct 19. doi: 10.1111/j.1365-2141.2010.08414.
     PubMed     Text format     Related articles   
     
     
     
     
101. MARTIN-SANCHEZ E , Sanchez-Beato M, Rodriguez ME, Sanchez-Espiridion B, et al
     HDAC inhibitors induce cell cycle arrest, activate the apoptotic extrinsic pathway and synergize with a novel PIM inhibitor in Hodgkin lymphoma-derived cell lines.
     Br J Haematol. 2010 Oct 19. doi: 10.1111/j.1365-2141.2010.08401.
     PubMed     Text format     Related articles   
     
     
     
     
102. SAUREL CA , Personett DA, Edenfield BH, Solberg LA, et al
     Molecular analysis of intravascular large B-cell lymphoma with neoangiogenesis.
     Br J Haematol. 2010 Oct 19. doi: 10.1111/j.1365-2141.2010.08354.
     PubMed     Text format     Related articles   
     
     
     
     September 2010
103. AGATHOCLEOUS A , Rohatiner A, Rule S, Hunter H, et al
     Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenstrom macroglobulinaemia.
     Br J Haematol. 2010 Sep 29. doi: 10.1111/j.1365-2141.2010.08340.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. VOSE JM , Weisenburger DD, Loberiza FR, Arevalo A, et al
     Late relapse in patients with diffuse large B-cell lymphoma.
     Br J Haematol. 2010 Sep 29. doi: 10.1111/j.1365-2141.2010.08330.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. EVE HE , Rule SA
     Lenalidomide-induced tumour flare reaction in mantle cell lymphoma.
     Br J Haematol. 2010 Sep 29. doi: 10.1111/j.1365-2141.2010.08376.
     PubMed     Text format     Related articles   
     
     
     
     
106. TUCCI A , Cerqui E, Ungari M, Ferrari S, et al
     Continuous oral cyclophosphamide and prednisolone as a valuable treatment option for peripheral T cell lymphoma.
     Br J Haematol. 2010 Sep 29. doi: 10.1111/j.1365-2141.2010.08367.
     PubMed     Text format     Related articles   
     
     
     
     
107. BUGLIO D , Mamidipudi V, Khaskhely NM, Brady H, et al
     The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism.
     Br J Haematol. 2010 Sep 29. doi: 10.1111/j.1365-2141.2010.08342.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. CALVO-VILLAS JM , Fernandez JA, de la Fuente I, Godoy AC, et al
     Intrathecal liposomal cytarabine for treatment of leptomeningeal involvement in transformed (Richter's syndrome) and non-transformed B-cell chronic lymphocytic leukaemia in Spain: a report of seven cases.
     Br J Haematol. 2010;150:618-20.
     PubMed     Text format     Related articles   
     
     
     
     
109. ISIDORI A , Visani G
     Stem cell mobilization: the other side of the coin: commentary on the current status of stem cell mobilization.
     Br J Haematol. 2010;150:663-4.
     PubMed     Text format     Related articles   
     
     
     
     
110. GERTZ MA
     Current status of stem cell mobilization.
     Br J Haematol. 2010;150:647-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     August 2010
111. SPIRA D , Vogel W, Bares R, Horger M, et al
     Volume-perfusion CT as an adjunct to whole-body contrast-enhanced CT for monitoring response to therapy in lymphoma.
     Br J Haematol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
112. SCANDURRA M , Mian M, Greiner TC, Rancoita PM, et al
     Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.
     Br J Haematol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. SHEN M , Menashe I, Morton LM, Zhang Y, et al
     Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies.
     Br J Haematol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. SIMON A , Peoch M, Casassus P, Deconinck E, et al
     Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95.
     Br J Haematol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. SCHUURMANS M , Bromberg JE, Doorduijn J, Poortmans P, et al
     Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis.
     Br J Haematol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. ROMAGUERA JE , Fayad LE, McLaughlin P, Pro B, et al
     Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma.
     Br J Haematol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. KROKOWSKI M , Sellmann L, Feller AC
     Intravascular large B-cell lymphoma within a subcutaneous cavernous haemangioma.
     Br J Haematol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
118. ADVANI RH , Chen H, Habermann TM, Morrison VA, et al
     Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognosti
     Br J Haematol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. STORTO G , Di Giorgio E, De Renzo A, Pizzuti LM, et al
     Assessment of metabolic activity by PET-CT with F-18-FDG in patients with T-cell lymphoma.
     Br J Haematol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
120. BORRO M , Gentile G, De Luca O, Torre MS, et al
     Specific effects exerted by B-lymphoproliferative diseases on peripheral T-lymphocyte protein expression.
     Br J Haematol. 2010;150:463-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2010
121. MIHARA K , Yanagihara K, Takigahira M, Kitanaka A, et al
     Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphoma.
     Br J Haematol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. JEREZ A , Del Mar Osma M, Amigo ML, Ortuno FJ, et al
     Faggot cells in an HIV-positive patient with inv(16)/therapy-related acute myeloid leukaemia.
     Br J Haematol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
123. SHUSTOV AR , Gooley TA, Sandmaier BM, Shizuru J, et al
     Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas.
     Br J Haematol. 2010;150:170-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. HEMMAWAY C , Mian A, Nagy Z
     Images in haematology. Irreversible blindness secondary to posterior reversible encephalopathy syndrome following CHOP combination chemotherapy.
     Br J Haematol. 2010;150:129.
     PubMed     Text format     Related articles   
     
     
     
     
125. GOVI S , Dognini GP, Licata G, Crocchiolo R, et al
     Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial.
     Br J Haematol. 2010;150:226-9.
     PubMed     Text format     Related articles   
     
     
     
     
126. CHIGRINOVA E , Kwee I, Rinaldi A, Poretti G, et al
     Non-negative matrix factorization to perform unsupervised clustering of genome wide DNA profiles in mature B cell lymphoid neoplasms.
     Br J Haematol. 2010;150:229-32.
     PubMed     Text format     Related articles   
     
     
     
     June 2010
127. PARAJULI R , Hire E, Shah BK
     Rituximab-induced acute severe thrombocytopenia.
     Br J Haematol. 2010;149:804.
     PubMed     Text format     Related articles   
     
     
     
     February 2010
128. HARTMANN S , Gesk S, Scholtysik R, Kreuz M, et al
     High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus.
     Br J Haematol. 2010;148:402-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: